|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：P141022 |
| 產(chǎn)品名稱：Paliperidone Palmitate-d4 |
| 產(chǎn)品CAS：1794685-21-4 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
P141022 |
| 名稱: |
Paliperidone Palmitate-d4 |
| 別名: |
9-Hydroxyrisperidone Palmitate-d4; Invega Sustenna-d4; Hexadecanoic Acid 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl](ethyl-d4)]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl Ester; RO 92670-d4; |
| CAS號(hào): |
1794685-21-4 |
| 參考CAS號(hào): |
類似: 199739-10-1 |
| 分子式: |
C??H??D?FN?O? |
| 外觀: |
白色至Light Beige Solid |
| 熔點(diǎn): |
106-108°C |
| 分子量: |
668.92 |
| 儲(chǔ)存: |
冰箱 |
| 溶解度: |
Chloroform (Slightly), Ethyl Acetate (Slightly) |
| 類別: |
Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
The labelled analogue of a long-acting injectable atypical antipsychotic used in the treatment of schizophrenia. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
?您的位置：
